TSS
HBIO icon

Two Sigma Securities’s Harvard Bioscience HBIO Stock Holding History

Two Sigma Securities’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,755
Closed -$11.7K – 1858
2025
Q4 		$11.7K Buy
+1,755
New +$10.4K ﹤0.01% 1269
2019
Q3 		– Sell
-1,251
Closed -$25K – 2208
2019
Q2 		$25K Buy
+1,251
New +$36.6K ﹤0.01% 1931

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's HBIO Position: Q1 2026 in Review

Two Sigma Securities sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 1,755 shares — an estimated $11.7K sold.

Two Sigma Securities first reported a position in HBIO in Q2 2019 and held it in 2 quarters. The position peaked at $25K in Q2 2019. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Two Sigma Securities reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 1,755 Harvard Bioscience shares in Q1 2026, an estimated $11.7K.
  • Two Sigma Securities first reported a position in Harvard Bioscience in Q2 2019 and held it in 2 quarters.
  • Two Sigma Securities's Harvard Bioscience position peaked at $25K in Q2 2019.
  • 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.